Blephamide

Trachoma, Pink Eye, Conjunctivitis + 1 more

Treatment

4 Active Studies for Blephamide

What is Blephamide

Sulfacetamide

The Generic name of this drug

Treatment Summary

Prednisolone acetate is a type of steroid medication that was approved by the FDA in 1955. It works by blocking certain chemical processes in the body to reduce inflammation and swelling.

Blephamide

is the brand name

image of different drug pills on a surface

Blephamide Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Blephamide

Sulfacetamide

1961

61

Effectiveness

How Blephamide Affects Patients

Prednisolone acetate is a type of corticosteroid that works by blocking signals in the body that cause inflammation, and promoting signals that reduce inflammation. Its effects last for a few hours, and patients often take doses much higher than the body naturally produces. Taking corticosteroids can suppress the body's ability to respond to stress and make it more likely to get infections, so patients should be aware of these risks.

How Blephamide works in the body

Corticosteroids can help reduce inflammation by decreasing blood vessel widening and the flow of white blood cells to sites of inflammation. They also change gene expression in the body, reducing the production of substances linked to inflammation and increasing substances that reduce inflammation. Low doses reduce inflammation, while higher doses can suppress your immune system. In high doses over an extended period, corticosteroids also cause sodium levels to rise and potassium levels to drop.

When to interrupt dosage

The prescribed dosage of Blephamide is contingent upon the determined condition, for example Ocular Infections, Irritations and Inflammations, Ocular Inflammation and Inflammatory Conditions. The quantity of dosage changes, in light of the technique of delivery (e.g. Ophthalmic or Solution/drops - Ophthalmic) featured in the table beneath.

Condition

Dosage

Administration

Trachoma

0.1 mg/mg, , 100.0 mg/mL, 0.098 mg/mg, 300.0 mg/mL, 80.0 mg/mL, 0.009 mg/mg, 0.9 mg/mL, 0.09 mg/mg, 1000.0 mg/mL, 10.0 mg/mL, 90.0 mg/mL, 10.0 %, 100.0 mg, 0.01 mg/mg, 0.095 mg/mg, 150.0 mg/mL, 98.0 mg/mL, 0.0286 mg/mg, 0.28 mg/mg, 0.08 mg/mg, 0.05 mg/mg, 0.15 mg/mg, 0.0098 mg/mg

, Ointment - Ophthalmic, Ointment, Ophthalmic, Suspension - Topical, Topical, Suspension, Solution, Solution - Topical, Cream, Cream - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid, Liquid - Topical, Swab, Cloth, Cloth - Topical, Rinse, Gel, Rinse - Topical, Gel - Topical, Swab - Topical, Kit, Suspension / drops - Ophthalmic, Suspension / drops, Soap - Topical, Soap, Liquid - Ophthalmic, Shampoo, Shampoo - Topical, Emulsion, Emulsion - Topical, Suspension - Ophthalmic, Ointment - Ophthalmic; Topical, Ophthalmic; Topical, Kit - Topical, Lotion / shampoo, Lotion / shampoo - Topical, Vaginal, Cream - Vaginal

Pink Eye

0.1 mg/mg, , 100.0 mg/mL, 0.098 mg/mg, 300.0 mg/mL, 80.0 mg/mL, 0.009 mg/mg, 0.9 mg/mL, 0.09 mg/mg, 1000.0 mg/mL, 10.0 mg/mL, 90.0 mg/mL, 10.0 %, 100.0 mg, 0.01 mg/mg, 0.095 mg/mg, 150.0 mg/mL, 98.0 mg/mL, 0.0286 mg/mg, 0.28 mg/mg, 0.08 mg/mg, 0.05 mg/mg, 0.15 mg/mg, 0.0098 mg/mg

, Ointment - Ophthalmic, Ointment, Ophthalmic, Suspension - Topical, Topical, Suspension, Solution, Solution - Topical, Cream, Cream - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid, Liquid - Topical, Swab, Cloth, Cloth - Topical, Rinse, Gel, Rinse - Topical, Gel - Topical, Swab - Topical, Kit, Suspension / drops - Ophthalmic, Suspension / drops, Soap - Topical, Soap, Liquid - Ophthalmic, Shampoo, Shampoo - Topical, Emulsion, Emulsion - Topical, Suspension - Ophthalmic, Ointment - Ophthalmic; Topical, Ophthalmic; Topical, Kit - Topical, Lotion / shampoo, Lotion / shampoo - Topical, Vaginal, Cream - Vaginal

Conjunctivitis

0.1 mg/mg, , 100.0 mg/mL, 0.098 mg/mg, 300.0 mg/mL, 80.0 mg/mL, 0.009 mg/mg, 0.9 mg/mL, 0.09 mg/mg, 1000.0 mg/mL, 10.0 mg/mL, 90.0 mg/mL, 10.0 %, 100.0 mg, 0.01 mg/mg, 0.095 mg/mg, 150.0 mg/mL, 98.0 mg/mL, 0.0286 mg/mg, 0.28 mg/mg, 0.08 mg/mg, 0.05 mg/mg, 0.15 mg/mg, 0.0098 mg/mg

, Ointment - Ophthalmic, Ointment, Ophthalmic, Suspension - Topical, Topical, Suspension, Solution, Solution - Topical, Cream, Cream - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid, Liquid - Topical, Swab, Cloth, Cloth - Topical, Rinse, Gel, Rinse - Topical, Gel - Topical, Swab - Topical, Kit, Suspension / drops - Ophthalmic, Suspension / drops, Soap - Topical, Soap, Liquid - Ophthalmic, Shampoo, Shampoo - Topical, Emulsion, Emulsion - Topical, Suspension - Ophthalmic, Ointment - Ophthalmic; Topical, Ophthalmic; Topical, Kit - Topical, Lotion / shampoo, Lotion / shampoo - Topical, Vaginal, Cream - Vaginal

Acne Vulgaris

0.1 mg/mg, , 100.0 mg/mL, 0.098 mg/mg, 300.0 mg/mL, 80.0 mg/mL, 0.009 mg/mg, 0.9 mg/mL, 0.09 mg/mg, 1000.0 mg/mL, 10.0 mg/mL, 90.0 mg/mL, 10.0 %, 100.0 mg, 0.01 mg/mg, 0.095 mg/mg, 150.0 mg/mL, 98.0 mg/mL, 0.0286 mg/mg, 0.28 mg/mg, 0.08 mg/mg, 0.05 mg/mg, 0.15 mg/mg, 0.0098 mg/mg

, Ointment - Ophthalmic, Ointment, Ophthalmic, Suspension - Topical, Topical, Suspension, Solution, Solution - Topical, Cream, Cream - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Liquid, Liquid - Topical, Swab, Cloth, Cloth - Topical, Rinse, Gel, Rinse - Topical, Gel - Topical, Swab - Topical, Kit, Suspension / drops - Ophthalmic, Suspension / drops, Soap - Topical, Soap, Liquid - Ophthalmic, Shampoo, Shampoo - Topical, Emulsion, Emulsion - Topical, Suspension - Ophthalmic, Ointment - Ophthalmic; Topical, Ophthalmic; Topical, Kit - Topical, Lotion / shampoo, Lotion / shampoo - Topical, Vaginal, Cream - Vaginal

Warnings

Blephamide Contraindications

Condition

Risk Level

Notes

Chronic Kidney Disease (CKD)

Do Not Combine

There are 17 known major drug interactions with Blephamide.

Common Blephamide Drug Interactions

Drug Name

Risk Level

Description

Vibrio cholerae CVD 103-HgR strain live antigen

Major

The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sulfacetamide.

Benzylpenicillin

Moderate

Sulfacetamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.

Estetrol

Moderate

The therapeutic efficacy of Estetrol can be decreased when used in combination with Sulfacetamide.

Insulin argine

Moderate

The risk or severity of hypoglycemia can be increased when Sulfacetamide is combined with Insulin argine.

Insulin aspart

Moderate

The risk or severity of hypoglycemia can be increased when Sulfacetamide is combined with Insulin aspart.

Blephamide Toxicity & Overdose Risk

The lowest toxic dose of prednisolone acetate in mice is 1680 mg/kg. Those who overdose onprednisolone acetate may experience more severe side effects of corticosteroids. If the overdose was recent, it can be treated with gastric lavage or inducing vomiting. Chronic overdosing can be managed by reducing the dose or administering the drug every other day. An overdose through eye drops is not expected to cause any problems.

image of a doctor in a lab doing drug, clinical research

Blephamide Novel Uses: Which Conditions Have a Clinical Trial Featuring Blephamide?

189 active clinical trials are assessing the effectiveness of Blephamide in treating Inflammation, Inflammatory Conditions and Superficial Ocular Infections.

Condition

Clinical Trials

Trial Phases

Trachoma

2 Actively Recruiting

Phase 4, Not Applicable

Acne Vulgaris

3 Actively Recruiting

Phase 1, Phase 2, Early Phase 1, Phase 4

Pink Eye

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

Blephamide Reviews: What are patients saying about Blephamide?

5

Patient Review

6/21/2014

Blephamide for Bacterial Infection of the Eyelid

I get awful allergies in the spring, and this is the only medication that has given me any relief.

4

Patient Review

10/9/2009

Blephamide for Pink Eye from Bacterial Infection

Worked great for about a day, but then the redness came right back. It looks like I have acne on my eyelid now.

2.3

Patient Review

9/17/2009

Blephamide for Inflammation of the Eye

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about blephamide

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How do you use Blephamide ointment?

"When applying the medication, tilt your head back and look up. Squeeze the tube gently to place a 1/2 inch (1.3 centimeter) strip of ointment into the pouch created by pulling down your lower eyelid. Close your eyes gently for 1-2 minutes, rolling your eyeball in all directions to spread the medication."

Answered by AI

What is Blephamide used to treat?

"It will not work for other types of eye infections.

This medication is used to both prevent and treat eye infections, as well as to treat swelling in the eye. It contains sulfacetamide, an antibiotic that stops the growth of bacteria, and prednisolone, a corticosteroid that reduces inflammation. However, this medication will only work on bacterial eye infections, and not other types of eye infections."

Answered by AI

Is Blephamide a steroid?

"BLEPHAMIDE® ophthalmic suspension is a steroid/anti-infective combination drug that is indicated for treating steroid-responsive inflammatory ocular conditions when a corticosteroid is needed and when there is a risk of superficial bacterial ocular infection."

Answered by AI

What is the generic for Blephamide?

"There is no FDA-approved generic version of Blephamide available in the United States. Some online pharmacies may sell a counterfeit or unapproved version of the drug, which could be dangerous."

Answered by AI

Clinical Trials for Blephamide

Image of University of North Carolina in Chapel Hill, United States.

BLTR vs B-RAP for Trichiasis

18+
All Sexes
Chapel Hill, NC

The primary objective of this randomized clinical trial is to determine whether repeat trichiasis surgery performed with Bevel-Rotate Advancement Procedure (B-RAP) improves surgical success compared to Bilamellar Tarsal Rotation (BLTR) among a group of 8-10 TT surgeons in Tanzania. The study aims to enroll 1,000 individuals with PTT. The primary outcome is repeat PTT within one year after surgery. Additionally, the study will assess eyelid contour abnormalities and how they change over a two-year period as well as patient reported outcomes. If this project is successful in improving surgical outcomes, it could change the approach to treating PTT globally. Individuals with trichiasis have a significantly reduced quality of life; correcting their trichiasis long-term has the potential to improve their quality of life and their family members' quality of life considerably.

Waitlist Available
Has No Placebo

University of North Carolina

Emily Gower, PhD

Image of Medical University of South Carolina in Charleston, United States.

Isotretinoin vs Tetracycline for Acne

Any Age
All Sexes
Charleston, SC

In the effort to find better treatments for Moderate Acne, which often relies on long-term antibiotic use, researchers are exploring alternative options. While Isotretinoin, a Vitamin A derivative, is highly effective for severe acne, its side effects limit its use for milder cases. A recent study from our institution investigated a new approach: weekly Isotretinoin dosing. The results were promising, with acne improvement and no major side effects. This suggests that weekly Isotretinoin could be a successful alternative for moderate acne in both males and females. To validate these findings, investigators propose a randomized controlled trial comparing weekly Isotretinoin to daily Doxycycline over four months. This study could confirm the safety and effectiveness of weekly Isotretinoin, as well as shed light on patient satisfaction, and long-term results compared to standard antibiotics. This research may offer a breakthrough in treating moderate acne while addressing concerns about antibiotic overuse.

Phase < 1
Recruiting

Medical University of South Carolina

Alex Richmond, MD, MSCR